Cargando…
Regression of fibrous dysplasia in response to denosumab therapy: A report of two cases
We present two patients with fibrous dysplasia who showed a decrease in lesional size and activity after denosumab therapy. Both patients also experienced a reduction in pain and bone turnover markers, which had not been accomplished during previous bisphosphonate therapy. These cases highlight the...
Autores principales: | Meier, Maartje E., van der Bruggen, Wouter, van de Sande, Michiel A.J., Appelman-Dijkstra, Natasha M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066421/ https://www.ncbi.nlm.nih.gov/pubmed/33912627 http://dx.doi.org/10.1016/j.bonr.2021.101058 |
Ejemplares similares
-
Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune‐Albright syndrome: an observational study
por: Meier, Maartje E., et al.
Publicado: (2021) -
Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[(18)F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome
por: van der Bruggen, Wouter, et al.
Publicado: (2021) -
Individualized approach to the surgical management of fibrous dysplasia of the proximal femur
por: Majoor, Bas C. J., et al.
Publicado: (2018) -
Determinants of impaired quality of life in patients with fibrous dysplasia
por: Majoor, Bas C. J., et al.
Publicado: (2017) -
What Is the Role of Allogeneic Cortical Strut Grafts in the Treatment of Fibrous Dysplasia of the Proximal Femur?
por: Majoor, Bastiaan C. J., et al.
Publicado: (2016)